Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
74.12
1.35 (1.86%)
At close: May 05, 2025, 3:59 PM
69.40
-6.37%
After-hours: May 05, 2025, 07:56 PM EDT
Corcept Therapeutics Revenue
Corcept Therapeutics reported an annual revenue of $675.04M, reflecting a 39.94% growth. For the quarter ending December 31, 2024, Corcept Therapeutics generated $181.89M in revenue.
Revenue (ttm)
$675.04M
Revenue Growth
39.94%
Price / Sales Ratio
7.71
Revenue / Employee
$1.35M
Employees
500
Market Cap
7.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|